Table 1.
Diseasea | Yearly R&D spending (million US$)b | DALYsd (1000s) | R&D (US$ per DALY) | DNIe | |||||
---|---|---|---|---|---|---|---|---|---|
2013 | 2014 | 2015 | 2016 | 2017 | 5-y averagec | ||||
RHD | 0.9 | 1.3 | 2.3 | 1.3 | 1.2 | 1.39 | 9393 | 0.15 | 3.83 |
Cysticercosis | 1.79 | 2.39 | 2.69 | 3.61 | 5.37 | 3.17 | 1608 | 1.97 | 2.71 |
Soil-transmitted helminths | 8 | 7.7 | 8.3 | 7 | 6.3 | 7.47 | 1919 | 3.89 | 2.41 |
Typhoid and paratyphoid fever | 47.8 | 47.9 | 55 | 71.4 | 63.7 | 57.17 | 9801 | 5.83 | 2.23 |
Trachoma | 2.2 | 1.35 | 1.15 | 2.18 | 2.67 | 1.91 | 302.9 | 6.31 | 2.2 |
Meningococcal meningitis | 18.9 | 12.23 | 7.44 | 24.57 | 10.67 | 14.76 | 2279 | 6.48 | 2.19 |
Onchocerciasis | 14.8 | 9.7 | 12.7 | 10.2 | 12 | 11.89 | 1343 | 8.85 | 2.05 |
Lymphatic filariasis | 15.38 | 21.36 | 13.71 | 15.82 | 15.21 | 16.29 | 1364 | 11.94 | 1.92 |
Malaria | 532.6 | 578.1 | 564.5 | 576.8 | 624 | 575.18 | 45 015 | 12.78 | 1.89 |
TB | 564.4 | 569.4 | 577.9 | 570.4 | 615.4 | 579.48 | 44 997 | 12.88 | 1.89 |
Schistosomiasis | 24.51 | 26.4 | 20.36 | 18.37 | 24.24 | 22.77 | 1431 | 15.91 | 1.8 |
HIV/AIDS | 1119.99 | 1080.93 | 1030.85 | 1102.3 | 1256.76 | 1116.16 | 54 446 | 20.5 | 1.69 |
Pneumococcal meningitis | 69.2 | 51.38 | 73.67 | 66.1 | 63.35 | 64.74 | 3077 | 21.04 | 1.68 |
Dengue | 76 | 85.86 | 101.13 | 112.8 | 81.33 | 91.44 | 2923 | 31.28 | 1.5 |
Leishmaniasis | 34.27 | 44.67 | 40.12 | 41.25 | 44.15 | 40.89 | 774 | 52.83 | 1.28 |
Chagas disease | 27.2 | 21.37 | 19.11 | 24.55 | 17.73 | 21.99 | 232 | 94.78 | 1.02 |
Total | 2558 | 2562 | 2531 | 2649 | 2844 | 2627 | 180 905 | – | – |
aAll diseases for which paired disease-specific data were available from G-FINDER and the Global Burden of Disease Study 2017.
bTotal grants to disease projects in 2017 (G-FINDER).
cMean of funding years 2013–2017, adjusted for inflation to 2017 US dollars.
dDALYs (Global Burden of Disease Study 2017).
eCalculated as the negative common logarithm of (DALYs [in thousands]/Funding [in US$ millions]).